1. Home
  2. FRGT vs XRTX Comparison

FRGT vs XRTX Comparison

Compare FRGT & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freight Technologies Inc.

FRGT

Freight Technologies Inc.

HOLD

Current Price

$1.16

Market Cap

2.3M

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRGT
XRTX
Founded
2015
2011
Country
Mexico
Canada
Employees
N/A
N/A
Industry
Professional Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.7M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FRGT
XRTX
Price
$1.16
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
830.1K
110.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
96.85
N/A
EPS
N/A
N/A
Revenue
$13,728,922.00
N/A
Revenue This Year
$371.03
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.37
52 Week High
$3.49
$1.41

Technical Indicators

Market Signals
Indicator
FRGT
XRTX
Relative Strength Index (RSI) 42.13 34.39
Support Level $1.09 $0.38
Resistance Level $1.42 $0.58
Average True Range (ATR) 0.23 0.03
MACD 0.01 0.00
Stochastic Oscillator 10.71 20.09

Price Performance

Historical Comparison
FRGT
XRTX

About FRGT Freight Technologies Inc.

Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: